NXGL — NEXGEL, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1468929 ·
Last close
$0.53
Market Cap
$4.80M
52W High
$1.25
52W Low
$0.48
ADV30
314,520
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,650,000 | 1,061,000 | -958,000 | -927,000 | 11,598,000 | 208,000 | 7,116,000 |
| Dec 2025 | 2,796,000 | 819,000 | -1,214,000 | -970,000 | 10,461,000 | 317,000 | 5,570,000 |
| Sep 2025 | 2,934,000 | 1,243,000 | -725,000 | -653,000 | 11,620,000 | 938,000 | 6,044,000 |
| Jun 2025 | 2,884,000 | 1,258,000 | -636,000 | -665,000 | 9,711,000 | 725,000 | 4,656,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,311,000
Investing CF
$-68,000
Financing CF
$630,000
CapEx
$-130,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.37
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-20,996,000
Inventory
$2,111,000
Receivables
$673,000
ST Investments
—
EBIT TTM
$-2,927,000
Pretax Income TTM
$-2,893,000
Interest Exp TTM
$58,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$11,421,000
EBITDA
$-2,902,000
Free Cash Flow
$-1,099,250
Enterprise Value
$7,525,603
Total Cash
$317,000
Total Debt
$3,088,000
Shares Out
9,131,055
Trailing EPS
$-0.40
Book Value
$0.55
ROE
-52.7%
ROA
-19.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 11,421,000 | -3,352,000 | -3,000,000 | 10,461,000 | 5,570,000 | — | -1,311,000 |
| Dec 2024 | 8,688,000 | -3,554,000 | -3,281,000 | 10,983,000 | 4,903,000 | — | -3,867,000 |
| Dec 2023 | 4,089,000 | -3,477,000 | -3,157,000 | 9,955,000 | 4,789,000 | — | -3,236,000 |
| Dec 2022 | 2,048,000 | -3,348,000 | -4,746,000 | 10,357,000 | 2,720,000 | — | -2,992,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.40
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMIX | Autonomix Medical, Inc. | $4.77M | $0.42 | — |
| DROR | Dror Ortho-Design, Inc. | $4.88M | $0.00 | — |
| ADMT | ADM TRONICS UNLIMITED, INC. | $5.41M | $0.08 | — |
| XAIR | Beyond Air, Inc. | $5.55M | $0.44 | — |
| FEED | ENvue Medical, Inc. | $5.64M | $0.93 | — |
News headlines (Yahoo Finance, 1h cache)
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume
2026-05-19 13:00 · Yahoo
Nexgel (NXGL) Q1 2026 Earnings Transcript
2026-05-15 16:54 · Yahoo
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical
2026-05-13 12:30 · Yahoo
NEXGEL To Report First Quarter 2026 Financial Results on May 15th
2026-05-12 14:27 · Yahoo
NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
2026-05-06 13:00 · Yahoo
NEXGEL Appoints Ian Blackman as Chief Financial Officer
2026-04-27 13:00 · Yahoo
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
2026-04-21 13:00 · Yahoo
Celularity Announces Closing of Transaction with NexGel
2026-04-21 12:30 · Yahoo
NEXGEL, Inc. Q4 2025 Earnings Call Summary
2026-04-21 12:30 · Yahoo
NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET
2026-04-17 19:37 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.